Gf Fund Management Co. Ltd. Editas Medicine, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,911 shares of EDIT stock, worth $4,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,911
Previous 1,935
1.24%
Holding current value
$4,968
Previous $6.71 Million
41.64%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
226Shares Held
47.8MCall Options Held
841KPut Options Held
304K-
Vanguard Group Inc Valley Forge, PA8.21MShares$21.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.78MShares$20.2 Million0.0% of portfolio
-
Nuveen, LLC Charlotte, NC2.09MShares$5.44 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$5.3 Million0.0% of portfolio
-
State Street Corp Boston, MA1.93MShares$5.01 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $179M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...